Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice

被引:88
作者
Lenaerts, AJM [1 ]
Gruppo, V [1 ]
Brooks, JV [1 ]
Orme, IM [1 ]
机构
[1] Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA
关键词
D O I
10.1128/AAC.47.2.783-785.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have developed a rapid new in vivo method for screening experimental drugs for their activity against Mycobacterium tuberculosis by using the gamma interferon gene-disrupted (GKO) C57BL/6 mouse. Due to the rapid growth of the infection, statistical differences indicating positive efficacy of active compounds can be seen after only 8 days of treatment. To validate this model, several fluoroquinolones, including ciprofloxacin, levofloxacin, moxifloxacin, and gatifloxacin, were tested in parallel.
引用
收藏
页码:783 / 785
页数:3
相关论文
共 19 条
[1]   The value of in vitro drug activity and pharmacokinetics in predicting the effectiveness of antimycobacterial therapy: A critical review [J].
Burman, WJ .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 313 (06) :355-363
[2]  
CANETTI G, 1963, Tubercle, V44, P236, DOI 10.1016/S0041-3879(63)80118-X
[3]   DISSEMINATED TUBERCULOSIS IN INTERFERON-GAMMA GENE-DISRUPTED MICE [J].
COOPER, AM ;
DALTON, DK ;
STEWART, TA ;
GRIFFIN, JP ;
RUSSELL, DG ;
ORME, IM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2243-2247
[4]   Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model [J].
Cynamon, MH ;
Klemens, SP ;
Sharpe, CA ;
Chase, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1189-1191
[5]   MULTIPLE DEFECTS OF IMMUNE CELL-FUNCTION IN MICE WITH DISRUPTED INTERFERON-GAMMA GENES [J].
DALTON, DK ;
PITTSMEEK, S ;
KESHAV, S ;
FIGARI, IS ;
BRADLEY, A ;
STEWART, TA .
SCIENCE, 1993, 259 (5102) :1739-1742
[6]  
Dickinson J M, 1968, Tubercle, V49, P351, DOI 10.1016/S0041-3879(68)80016-9
[7]  
DICKINSON J M, 1970, Tubercle, V51, P82, DOI 10.1016/0041-3879(70)90131-5
[8]   AN ESSENTIAL ROLE FOR INTERFERON-GAMMA IN RESISTANCE TO MYCOBACTERIUM-TUBERCULOSIS INFECTION [J].
FLYNN, JL ;
CHAN, J ;
TRIEBOLD, KJ ;
DALTON, DK ;
STEWART, TA ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2249-2254
[9]   STERILIZING VALUE OF RIFAMPICIN AND PYRAZINAMIDE IN EXPERIMENTAL SHORT COURSE CHEMOTHERAPY [J].
GROSSET, J .
TUBERCLE, 1978, 59 (04) :287-297
[10]  
Grumbach F, 1967, Rev Tuberc Pneumol (Paris), V31, P749